PRIMARY INSURANCE
PRIMARY INSURANCE PHONE
CARDHOLDER
CARDHOLDER DOB (MM/DD/YYYY)
RELATIONSHIP TO CARDHOLDER
POLICY# GROUP#
PROVIDER ID # FOR INSURANCE
SECONDARY INSURANCE
SECONDARY INSURANCE PHONE
CARDHOLDER
CARDHOLDER DOB (MM/DD/YYYY)
RELATIONSHIP TO CARDHOLDER
POLICY# GROUP#
PROVIDER ID # FOR INSURANCE
1. Patient Information
PATIENT NAME DOB (MM/DD/YYYY) MALE FEMALE
NAME OF GUARDIAN (IF APPLICABLE)
PATIENT ADDRESS
CITY STATE ZIP CODE
PRIMARY PHONE SECONDARY PHONE
2. Insurance Information
RX CARD PATIENT ID
3. Prescriber Information
NAME OF FACILITY FACILITY TAX ID #
PROVIDER TRANSACTION ACCESS # (PTAN) PHYSICIAN MEDICAID PROVIDER ID #
NAME OF PHYSICIAN SPECIALTY
ADDRESS CITY STATE ZIP CODE
PHONE FAX
OFFICE CONTACT OFFICE CONTACT PHONE
TAX ID # NPI #
4. Drug Therapy
VERIFY BENEFITS FOR:
SYMTUZA®
PREZISTA®
PREZCOBIX®
EDURANT®
INTELENCE® DOSING MG
DIAGNOSIS CODE:
ADDITIONAL INFORMATION REGARDING TREATMENT (IF APPLICABLE TO BENEFITS VERIFICATION)
5. Prior Authorization: If you would like Janssen CarePath to provide support for the prior authorization process, please check the appropriate box(es).
Prior Authorization Form Preparation By checking this box, I request that Janssen CarePath assist my office in providing the requirements of this patient’s
health plan related to prior authorization for treatment with the product noted in the Drug Therapy portion of this form. I understand that assistance includes
obtaining the health plan-specific prior authorization form, and providing it based upon the patient-specific information provided on this form. I understand that
the partially completed prior authorization form will be provided to my office by Janssen CarePath for possible completion and submission to the health plan.
Prior Authorization Status Monitoring By checking this box, I request that Janssen CarePath actively monitor the status of the prior authorization
submission. I request that Janssen CarePath provide status updates to my office with respect to this patient’s prior authorization for treatment with the product
noted in the Drug Therapy portion of this form.
Benefits Investigation Form
Complete and fax this form to 866-836-0567 or mail to
2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560
For assistance, call 877-CarePath (877-227-3728),
Monday–Friday, 8:00 am–8:00 pm ET
UPDATE 6.20
© Janssen Therapeutics, Division of Janssen Products, LP 2020 June 2020 cp-14843v3
Please see full Prescribing Information, including Boxed Warning and Patient Information, for SYMTUZA®. Provide the Patient Information to your patients
and encourage discussion.
Please see full Prescribing Information for PREZISTA®, PREZCOBIX®, EDURANT®, and INTELENCE®.
Janssen CarePath cannot accept any information without an executed Business Associate Agreement or Patient Authorization Form, which
can be found at JanssenCarePath.com or as the last page of this document.
Clear Form
Print Form
© Janssen Therapeutics, Division of Janssen Products, LP 2020 June 2020 cp-14843v3
The information you provide will be used by Janssen Therapeutics, Division of Janssen Products, LP, our affiliates, and our service providers for your
enrollment and participation in Janssen CarePath. You may withdraw by calling 877-CarePath (877-227-3728). Our Privacy Policy further governs the use
of the information you provide. By providing the information and submitting this form, you indicate that you read, understand, and agree to these terms.
Patient insurance benefits investigation and other Janssen CarePath program offerings are provided by third-party service providers for Janssen
CarePath, under contract with Johnson & Johnson Health Care Systems Inc. on behalf of Janssen Pharmaceuticals, Inc., Janssen Biotech, Inc., and
Janssen Products, LP (Janssen). Janssen CarePath is not available to patients participating in the Patient Assistance Program offered by Johnson &
Johnson Patient Assistance Foundation. The availability of information and assistance may vary based on the Janssen medication, geography and other
program differences. Janssen CarePath assists healthcare providers (HCPs) in the determination of whether treatment could be covered by the applicable
third-party payer based on coverage guidelines provided by the payer, and patient information provided by the HCP under appropriate authorization
following the providers exclusive determination of medical necessity. This information and assistance are made available as a convenience to patients, and
there is no requirement that patients or HCPs use any Janssen product in exchange for this information or assistance. Janssen assumes no responsibility
for and does not guarantee the quality, scope, or availability of the information and assistance provided. The third-party service providers, not Janssen,
are responsible for the information and assistance provided under this program. Each HCP and patient is responsible for verifying or confirming any
information provided. All claims and other submissions to payers should be in compliance with all applicable requirements.
Janssen CarePath Patient Authorization
Patients should read the Patient Authorization and sign electronically or download, print, and sign.
Completed form may be uploaded to Patient Account or Provider Portal, faxed to Janssen CarePath at 866-836-0567, or mailed
to address below.
Patients can access a copy of completed form in their Janssen CarePath Account – My Profile.
My signature on this Patient Authorization Form confirms that I authorize each of my physicians, pharmacists, including any specialty pharmacy that
receives my prescription for a Janssen medication, and other healthcare providers (together, “Healthcare Providers”), and each of my health insurers
(together, “Insurers”) to disclose my protected health information, including but not limited to information related to my medical condition and treatment,
my health insurance coverage, my name, address, telephone number, insurance plan and/or group numbers (together, “Protected Health Information”)
to Johnson & Johnson Health Care Systems Inc., its affiliated companies, agents and representatives (together, “Janssen”), including providers of alternate
sources of funding for prescription drug costs, and other approved service providers authorized to manage, administer, and/or support Janssen CarePath
programs, Janssen CarePath Account for Patients, and Provider Portal for their Healthcare Providers for the purposes described below.
Specifically, I authorize Janssen to receive, use, and disclose my Protected Health Information in order to (i) enroll me in, determine my eligibility for, and
contact me about, Janssen medication support programs; (ii) provide me with educational materials, information, and services related to my Janssen
medication; (iii) verify, investigate, assist with, and coordinate my coverage for my Janssen medication with my Insurers; (iv) coordinate prescription
fulfillment; (v) assist with analyses related to the quality, efficacy, and safety of my Janssen medication, and patient access to and adherence to my
Janssen medication; (vi) to share and provide access to information generated by Janssen CarePath that may be useful for my care, and; (vii) to improve,
develop, and evaluate Janssen CarePath, its offerings, and materials. I also understand that pharmacies that ship my medication may be paid to share this
information with Janssen CarePath to help provide the offerings requested for me. Furthermore, I understand that my Protected Health Information will
not be used or disclosed by Janssen for any other purpose without my prior authorization unless permitted by law or unless information that specifically
identifies me is removed. I understand that Janssen will make every effort to keep my information private. Further, I understand that if my information is
accidentally shared, federal privacy laws do not require that the person/party receiving it not disclose the information further and that such information
provided to a third party may no longer be protected by federal privacy laws.
I understand that I am not required to sign this Patient Authorization Form. My choice about whether to sign will not change the way my Healthcare
Providers or Insurers treat me. If I refuse to sign the Patient Authorization Form, or revoke my authorization later, I understand that this means I will not be
able to participate or receive assistance from Janssen CarePath.
This authorization will last until I am no longer participating in Janssen CarePath, or accessing my Janssen CarePath Account. I understand that I may
cancel or revoke this Authorization at any time by mailing a letter requesting such cancellation to Janssen CarePath, 2250 Perimeter Park Drive, Suite 300,
Morrisville, NC 27560 or by informing my Healthcare Providers and Insurers in writing that I do not want them to share any information with Janssen. I
further understand that cancellation or revocation will not affect Janssen’s ability to use and disclose Protected Health Information that it has received
prior to its receipt of my cancellation and revocation of participation in the program. My authorization will also end if Janssen CarePath support programs
or the Janssen CarePath Account is discontinued. Furthermore, I understand that I have the right to see or copy the Protected Health Information my
Healthcare Providers or Insurers have given to Janssen.
Patient name: Date of birth (mm/dd/yyyy):
Patient address:
City: State: ZIP Code:
Patient sign here: Date:
If the patient cannot sign, patient’s legally authorized representative must sign below:
By: Date:
(Signature of person legally authorized to sign for patient)
Describe relationship to patient and authority to make medical decisions for patient:
Janssen CarePath
2250 Perimeter Park Drive, Suite 300
Morrisville, NC 27560
Fax 866-836-0567
© Janssen Therapeutics, Division of Janssen Products, LP 2020 June 2020 cp-14843v3